Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Amortizatization of Intangibles (2012 - 2019)

Kamada's (KMDA) quarterly Amortizatization of Intangibles came in at -$238000.0 in Q3 2019, down 2.15% quarter-over-quarter from -$233000.0 in Q2 2019.

Analysis

Kamada (KMDA) Amortizatization of Intangibles (2012 - 2019) Analysis & Trends

Kamada (KMDA) has reported Amortizatization of Intangibles for 5 consecutive years, with -$238000.0 the latest figure, recorded in Q3 2019.

  • For the quarter ending Q3 2019, Amortizatization of Intangibles changed N/A year-over-year to -$238000.0; the trailing twelve-month figure through Sep 2019 stood at $299000.0 (changed N/A YoY), and the FY2014 full-year result was $1.7 million, down 47.97% from the prior year.
  • Amortizatization of Intangibles retreated to -$238000.0 in Q3 2019 per KMDA's latest filing, from -$233000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at -$233000.0 in Q2 2019 and bottomed at -$447000.0 in Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 600.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 1.39 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -238,000.00
Jun 30, 2019 -233,000.00
Mar 31, 2015 -447,000.00
Sep 30, 2014 1.22 Mn
Jun 30, 2014 853,000.00
Mar 31, 2014 -447,000.00
Sep 30, 2013 2.40 Mn
Jun 30, 2013 1.45 Mn
Jun 30, 2012 1.19 Mn